Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The Group recorded revenue of RM20.18 million for the current quarter ended 31 December 2024,
representing a decrease of RM2.11 million or 9.48% as compared to the preceding quarter ended 30
September 2024 of RM22.29 million. The decrease in revenue was mainly due to decrease in number
of endoscopic procedures performed.
The Group's PBT decreased by RM1.60 million or approximately 28.27% from RM5.66 million in the
immediate preceding quarter to RM4.06 million in the current financial quarter. The decrease was
mainly due to the decline in revenue, coupled with by higher staff costs and accelerated
depreciation of current building renovation.